Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder
In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship
P01 Reviewers Asked To Look Closely At Number Of Projects
Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds
Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says
Score Distribution, Other Charts, On P01s
In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.
